Bio

Arthur Brothag is Apax's Global Head of Investor Relations and Strategy. He was promoted to this role in 2023 to lead investor relations and strategy for Apax globally. Prior to this, Arthur was a Partner in Apax's healthcare investment team, and between 2009 and 2021 worked on deals including Acelity, Neuraxpharm, Rodenstock, TietoEVRY, Unilabs and Vyaire Medical. Before joining Apax, Arthur worked as an investor at the private equity firm Warburg Pincus, as well as at Morgan Stanley Investment Banking. Arthur originally trained as a medical doctor at the Technical University of Munich, where he also did his doctoral research. He held resident doctor positions in Germany and Switzerland in cardiology and oncology. He later completed his MBA studies with distinction at INSEAD.